ASH 2014: Prof John Gribben and Prof Peter Hillmen discuss recent advances in CLL (Part 2)

ASH 2014: Prof John Gribben and Prof Peter Hillmen discuss recent advances in CLL (Part 2)

User Photo
EMJ

5 years
762 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Peter Hillmen (Leeds General Infirmary, UK) about recent advances in the research of chronic lymphocytic leukaemia (CLL).

The understanding of CLL biology is changing how the disease is managed. Prognostic markers help to identify specific patient subgroups and provide insight disease progression in these groups. New studies in drugs, such as ibrutinib, target cell proliferation.
Up Next Autoplay